ABC.L - Abcam Plc

LSE - LSE Delayed Price. Currency in GBp

Abcam Plc

330 Cambridge Science Park
Milton Road
Cambridge CB4 0FL
United Kingdom
44 12 2369 6000
http://www.abcam.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees1,000

Key Executives

NameTitlePayExercisedAge
Mr. Alan Thomas Hirzel BS, MS, MBACEO & Exec. Director1.12MN/A49
Mr. Gavin Hilary James Wood BA (Hons), ACACFO & Exec. Director569kN/A47
Mr. Mark Bushfield Ph.D.Scientific DirectorN/AN/AN/A
Mr. Sean Hickey BScChief Information OfficerN/AN/AN/A
Ms. Suzanne E. Smith LLB (Hons), MBAChief Legal Officer & Company Sec.N/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery products and services. Abcam plc also engages in sales and distribution, and financing and investing activities, as well as sells its products online. It offers validated antibodies and other binders, and assays to the research and clinical communities to help advance the understanding of biology and causes of disease. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Corporate Governance

Abcam Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.